14 articles for PV Plazzi
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.

University of Parma
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line.

University of Parma
5-benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity.

Università
Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.

Università
Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.

Università
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold.

University of Parma
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.

University of Parma
Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.

University of Milan
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.

University of Parma
2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists.

University of Urbino
Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.

University of Milan
Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.

University of Urbino
Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase.

Duke University Medical Center